Target intelligence / Profile preview

BAG family molecular chaperone regulator 4 (BAG4)

Target
BAG4
Molecular classification
Other (co-chaperone regulator), Chaperone regulatory protein
01

Overview

BAG family molecular chaperone regulator 4 (BAG4, also known as Silencer of death domains or SODD) is a member of the BAG protein family that acts as a co-chaperone and regulatory protein in human cells. It contains a C-terminal BAG domain that interacts with Hsc70/Hsp70 heat shock proteins, inhibiting their chaperone activity by promoting substrate release[1][3][6]. BAG4 is also known for binding to and masking the death domains of tumor necrosis factor receptor type 1 (TNF-R1) and death receptor-3 (DR3), thereby inhibiting constitutive or ligand-independent signaling and negatively regulating downstream apoptotic pathways[1][3][5][6]. Its anti-apoptotic role has been associated with cancer progression, metastasis, and cell survival, particularly through activation of proliferative survival pathways such as PI3K/AKT/NF-κB[4]. There are currently no established drugs directly targeting BAG4, and clinical biomarkers or safety issues specific to this protein have not been established in the current literature.

Other names
Silencer of death domainsSODDBcl-2-associated athanogene 4BAG-4
02

Biological functions

Negative regulation of apoptosisCell death signaling inhibitionRegulation of protein folding (via inhibition of HSP70/HSC70 chaperone activity)Interacts with death domains of TNF receptor type 1 (TNFR1) and death receptor-3 (DR3)
03

Disease associations

CancerPotential metastasis and invasion in certain cancers (e.g., gastric cancer)Other (via cell survival pathways)

Beyond the preview

Go deeper on BAG family molecular chaperone regulator 4 (BAG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAG family molecular chaperone regulator 4 (BAG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call